HIROTSUバイオサイエンス | 線虫がん検査に関する世界最先端の線虫行動解析技術

NEWS

Cancer test that uses nematodes N-NOSE® （エヌノーズ）

N-NOSE is a cancer screening test takes advantage of the keen olfactory sensors of nematodes. The test has been available to the public in Japan in January 2020.

N-NOSE service site
Learn More

What is N-NOSE?

Merit of taking a cancer screening test

Why nematodes?

The world's first biological ”diagnostic” technology.

At Hirotsu Bio Science, we contribute to the development of revolutionary disease diagnostic technologies to lessen your concerns over health.

Message from CEO
Learn More

Company Profile

Company History

SDGs

List of Officers

News

【Press release】The report of launch joint clinical research on HIROTSU BIO SCIENCE’s high accuracy “N-NOSE” cancer screening test using nematodes.

2017.08.21

More

Capital Increase through Third-Party Allotment

HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative; Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”)), has recently . . .

Indonesian Healthcare Company PT Jaya Prima Alkatra Visits Our Company

In May 2024, the Indonesian healthcare company PT Jaya Prima Alkatra visited our company, and Press Release regarding this visit has been issued . . .

Publication of Large-Scale Clinical Study Results for Nematode-Based Cancer Screening Method “N-NOSE”Publication of Large-Scale Clinical Study Results

HIROTSU BIO SCIENCE INC. (Head Office: Chiyoda-ku, Tokyo; Representative; Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”)), has conducted . . .